These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20825317)

  • 1. MDR tuberculosis--critical steps for prevention and control.
    Nathanson E; Nunn P; Uplekar M; Floyd K; Jaramillo E; Lönnroth K; Weil D; Raviglione M
    N Engl J Med; 2010 Sep; 363(11):1050-8. PubMed ID: 20825317
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
    Pablos-Mendez A; Gowda DK; Frieden TR
    Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmatic management of multidrug resistant TB.
    Sarin R
    Indian J Tuberc; 2009 Oct; 56(4):171-3. PubMed ID: 20469727
    [No Abstract]   [Full Text] [Related]  

  • 4. Time to put boots on the ground: making universal access to MDR-TB treatment a reality.
    Keshavjee S; Farmer PE
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1222-5. PubMed ID: 20843411
    [No Abstract]   [Full Text] [Related]  

  • 5. The major infectious diseases in the world--to treat or not to treat?
    Farmer P
    N Engl J Med; 2001 Jul; 345(3):208-10. PubMed ID: 11463018
    [No Abstract]   [Full Text] [Related]  

  • 6. The forgotten plague.
    Park A
    Time; 2008 Oct; 172(15):55-61. PubMed ID: 18972703
    [No Abstract]   [Full Text] [Related]  

  • 7. Multidrug-resistant tuberculosis (MDR-TB) in India: an attempt to link biosocial determinants.
    Atre SR; Mistry NF
    J Public Health Policy; 2005 Apr; 26(1):96-114. PubMed ID: 15906879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Picking up the pace--scale-up of MDR tuberculosis treatment programs.
    Keshavjee S; Farmer PE
    N Engl J Med; 2010 Nov; 363(19):1781-4. PubMed ID: 21047219
    [No Abstract]   [Full Text] [Related]  

  • 9. XDR tuberculosis--implications for global public health.
    Raviglione MC; Smith IM
    N Engl J Med; 2007 Feb; 356(7):656-9. PubMed ID: 17301295
    [No Abstract]   [Full Text] [Related]  

  • 10. Slow elimination of multidrug-resistant tuberculosis.
    Dye C; Williams BG
    Sci Transl Med; 2009 Oct; 1(3):3ra8. PubMed ID: 20368167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: the treatment of multi-drug resistant tuberculosis--a return to the pre-antibiotic era?
    Ollé-Goig JE
    Trop Med Int Health; 2006 Nov; 11(11):1625-8. PubMed ID: 17054741
    [No Abstract]   [Full Text] [Related]  

  • 12. Responding to the multidrug-resistant tuberculosis crisis: mainstreaming programmatic management to the Philippine National Tuberculosis Programme.
    Quelapio MI; Mira NR; Orillaza-Chi RB; Belen V; Muñez N; Belchez R; Egos GE; Evangelista M; Vianzon R; Tupasi TE
    Int J Tuberc Lung Dis; 2010 Jun; 14(6):751-7. PubMed ID: 20487615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The most recent report from the World Health Organization found that, worldwide, approximately 5% of new tuberculosis cases are caused by multidrug-resistant strains (MDR TB).
    Denholm J
    J Travel Med; 2010; 17(3):216. PubMed ID: 20536899
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug resistance in tuberculosis].
    Winje BA; Mannsåker T; Langeland N; Heldal E
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2588-92. PubMed ID: 19023372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global policies and practices for managing persons exposed to multidrug-resistant tuberculosis.
    Cain KP; Nelson LJ; Cegielski JP
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):269-74. PubMed ID: 20132616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ad fontes!
    Hoffner SE; Salfinger M
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):260. PubMed ID: 20132612
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tuberculosis--still increasing threat. Time for mobilization over the national borders].
    Larsson LO
    Lakartidningen; 2009 Jul 22-Aug 4; 106(30-31):1882-3. PubMed ID: 19739439
    [No Abstract]   [Full Text] [Related]  

  • 18. Public health. Responding to market failures in tuberculosis control.
    Gupta R; Kim JY; Espinal MA; Caudron JM; Pecoul B; Farmer PE; Raviglione MC
    Science; 2001 Aug; 293(5532):1049-51. PubMed ID: 11463877
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
    Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. World Health Organization fact sheet. Tuberculosis.
    World Health Organization
    Saudi Med J; 2004 Aug; 25(8):1136-8. PubMed ID: 15457607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.